← Back to Search

Procedure

SuperPATH for Hip Replacement

N/A

Recruiting

Led By Wade Gofton, MD, FRCSC

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively.

Awards & highlights

Study Summary

This trial is comparing the outcomes of two different approaches to hip replacement - the Direct Anterior Approach (DAA) and the Supercapsular Percutaneously Assisted Total Hip (SuperPATH) approach. Both approaches replace hips without cutting any muscles. DAA has been used for many years, but it has a high learning curve and can be difficult for doctors to use. SuperPATH is a newer technique which has been shown in studies to be adopted with less complications even during the learning phase.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline in Hip disability and Osteoarthritis Outcome Score (HOOS) activities of daily living (ADL)

Change in Gait analysis

Secondary outcome measures

Change in Complication rates

Change in EQ-5D-5L

Change in Pre-post Hgb

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SuperPATHExperimental Treatment1 Intervention

SuperPATH approach surgery to replace the hip.

Group II: Direct Anterior Approach (DAA)Active Control1 Intervention

Direct Anterior Approach surgery to replace the hip.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor

561 Previous Clinical Trials

2,785,591 Total Patients Enrolled

MicroPort Orthopedics Inc.Industry Sponsor

31 Previous Clinical Trials

3,386 Total Patients Enrolled

Wade Gofton, MD, FRCSCPrincipal InvestigatorThe Ottawa Hospital

1 Previous Clinical Trials

160 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial available to participants currently?

"Affirmative. Clinicaltrials.gov contains information that suggests this clinical trial is actively enrolling applicants; it was first published on September 7th 2019 and the most recent update occurred on August 5th 2022. The medical experiment seeks to include 100 individuals from 1 research centre."

Answered by AI

Are individuals aged 55 or over being accepted into the trial?

"According to the requirements, only individuals aged 18 or above and 80 or below are eligible for this trial."

Answered by AI

What is the intended outcome of this clinical investigation?

"The primary measurement of this trial is the alteration in gait analysis over a period running from before surgery to 12 months post-operative. Secondary metrics include changes to timed up and go, stair climb times, as well as x-rays taken at the hips."

Answered by AI

How many participants have been recruited for this clinical trial?

"That is correct. Clinicaltrials.gov currently states that this clinical trial, established on September 7th 2019, is enrolling participants at the moment. 100 individuals will be accepted from a single site for participation in the project."

Answered by AI